Britain's Reckitt Benckiser Group beat fourth-quarter sales forecasts on Thursday after fears of COVID-19 led to increased demand for its cleaning products.
However, the maker of Lysol disinfectant and Durex condoms missed full-year earnings estimates, joining rivals in struggling with higher raw material and supply chain costs.
Reckitt did not give separate fourth-quarter earnings data.
The company said it was targeting like-for-like net revenue growth of 1-4% for 2022.
That came after revenues on the same basis rose 3.3% in the final quarter of 2021, ahead of the 1.9% growth expected by analysts in a company-supplied poll.
The results and
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

)